SSI has developed experimental infection models for the purpose of evaluating antimicrobial drugs. These models are ideal for efficacy screening of new compounds in the discovery phase, proof of concept, as well as for pharmacokinetic and pharmacodynamic studies. Advanced mathematical PK/PD modeling is also used as an integrated part of such studies.